BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that members of its senior management team will participate in the following upcoming investor conferences:
Aura Biosciences to Participate in Upcoming Investor Conferences
Seeking Alpha / 22 minutes from now 1 Views
Comments